Transfer and scale-up of the manufacturing of orodispersible mini-tablets from a compaction simulator to an industrial rotary tablet press.
Compaction simulator
Direct compression
Functionalized excipients
Mini-tablets
Rotary tablet press
Scale-up
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
01 Jun 2021
01 Jun 2021
Historique:
received:
10
12
2020
revised:
17
04
2021
accepted:
19
04
2021
pubmed:
26
4
2021
medline:
22
6
2021
entrez:
25
4
2021
Statut:
ppublish
Résumé
Orodispersible mini-tablets (ODMTs) are a promising dosage form for the pediatric use showing increasing interest from pharmaceutical industry. However, a scale-up process for ODMTs from a compaction simulator to a rotary tablet press following FDA and EMA guidelines has not been performed and investigated yet. Isomalt (galenIQ™721) and Ludiflash® both excipients with proven suitability for the development of ODMTs have been investigated in transfer and scale-up from a compaction simulator to a rotary tablet press. ODMTs with isomalt and Ludiflash® were produced on the rotary tablet press monitoring the product temperature over time and assessing the properties of the residual powder in the feed shoe. Critical quality attributes like tensile strength, mass and disintegration time were evaluated. The transfer from compaction simulator to rotary tablet press succeeded as for both excipients similar disintegration times, tabletability and compactibility profiles were obtained. However, during scale-up, disintegration time significantly increases over time for both excipients. Monitoring of the product temperature revealed that with increasing batch size the product temperature increases as well having a significant impact on disintegration time. The properties of ODMTs produced with the residual powder are comparable in tabletability and disintegration time compared with ODMTs produced from fresh powder.
Identifiants
pubmed: 33895296
pii: S0378-5173(21)00441-5
doi: 10.1016/j.ijpharm.2021.120636
pii:
doi:
Substances chimiques
Excipients
0
Powders
0
Tablets
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
120636Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.